Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine for smoking cessation and cognitive symptoms
NCT01548638Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2012
- Primary completion
- Aug 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of galantamine in nicotine dependence, sponsored by University of Pennsylvania. Started Feb 2012; status: completed.
02
Drugs
galantamine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01548638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548638.